Integrin receptors are responsible for integrating extracellular matrix signals inside the cell. The most prominent integrin receptor, b1 integrin, has a role in cell function, survival and differentiation. Recently, we demonstrated a profound in vivo role of b1 integrin expression in the pancreas on glucose homeostasis and islet function. Here, we extend these results by examining the role of b1 integrin in exocrine pancreatic structure and function. Adult C57Bl/6 mice hemizygous for a collagen type Ia2 (Col1a2) promoter-controlled tamoxifen-inducible Cre recombinase gene and homozygous for loxP-b1 integrin were injected with tamoxifen or corn oil to generate mice deleted or not for b1 integrin. Pancreata derived from these male mice were analyzed by quantitative reverse transcriptase-polymerase chain reaction, western blot and immunofluorescence. Our results showed that b1 integrin-deficient mice displayed a significant decrease in pancreas weight with a significant reduction of amylase, regenerating islet-derived protein II and carboxypeptidase-A expression (Po0.05-0.01). Compared with control pancreata, b1 integrin-deficient pancreata showed reduced mRNA expression of extracellular matrix (collagen type Ia2, fibronectin and laminin) genes (Po0.05), detached acini clusters and lost focal adhesion structure. Moreover, b1 integrin-deficient pancreatic acinar cells displayed decreased proliferation (Po0.05) and increased apoptosis (Po0.001). Apoptosis was reduced to that of controls when isolated exocrine clusters were cultured in media supplemented with extracellular matrix proteins. Taken together, these results implicate b1 integrin as an essential component for maintaining exocrine pancreatic structure and function. Integrin receptors have a significant role in cell-cell and cellextracellular matrix (ECM) contacts in many different tissue types. There are 18 a and 8 b receptors capable of forming 24 heterodimeric interactions; yet, half these interactions are made up by b1 integrin receptors. 1 This b1 integrin receptor group is largely responsible for attachment to the ECM. 2 Upon stimulation, b1 integrin has been shown to mediate cell motility, survival, proliferation and differentiation. [2] [3] [4] [5] Pancreatic acini are enclosed round structures that produce digestive enzymes. 6 Basal lamina covers the acini at the basal surface, stimulating acini integrin receptors. 6 Pancreatic stellate cells (PSCs) are identified as periacinar fibroblast-like cells of the pancreas that express glial fibrillary acidic protein (GFAP) and produce ECM proteins in support of surrounding tissue. 7 PSCs are also, in part, responsible for the fibrosis observed in chronic pancreatitis. 8, 9 Previous studies have shown that a3b1 integrin is essential for proper apical/ basolateral cell surface receptor organization and basement membrane formation in the submandibular gland. 10 As well, b1 integrin deficiency has shown to interfere with laminin-1 expression and basement membrane synthesis and assembly in embryoid bodies 11 and teratoma, 12 as well as collagen IV expression in the lens fiber of mice. 13 This is also true for proper fibronectin assembly, which requires a5b1 integrin. 14 b1 integrin has been studied in many tissues, yet the role of b1 integrin in the postnatal exocrine pancreas is almost wholly unknown. One recent study examined the effect of loss of b1 integrin expression in acinar cells during development; B6-week-old b1 integrin-deficient mice were susceptible to pancreatitis and displayed aberrant acinar cell
Integrin receptors have a significant role in cell-cell and cellextracellular matrix (ECM) contacts in many different tissue types. There are 18 a and 8 b receptors capable of forming 24 heterodimeric interactions; yet, half these interactions are made up by b1 integrin receptors. 1 This b1 integrin receptor group is largely responsible for attachment to the ECM. 2 Upon stimulation, b1 integrin has been shown to mediate cell motility, survival, proliferation and differentiation. [2] [3] [4] [5] Pancreatic acini are enclosed round structures that produce digestive enzymes. 6 Basal lamina covers the acini at the basal surface, stimulating acini integrin receptors. 6 Pancreatic stellate cells (PSCs) are identified as periacinar fibroblast-like cells of the pancreas that express glial fibrillary acidic protein (GFAP) and produce ECM proteins in support of surrounding tissue. 7 PSCs are also, in part, responsible for the fibrosis observed in chronic pancreatitis. 8, 9 Previous studies have shown that a3b1 integrin is essential for proper apical/ basolateral cell surface receptor organization and basement membrane formation in the submandibular gland. 10 As well, b1 integrin deficiency has shown to interfere with laminin-1 expression and basement membrane synthesis and assembly in embryoid bodies 11 and teratoma, 12 as well as collagen IV expression in the lens fiber of mice. 13 This is also true for proper fibronectin assembly, which requires a5b1 integrin. 14 b1 integrin has been studied in many tissues, yet the role of b1 integrin in the postnatal exocrine pancreas is almost wholly unknown. One recent study examined the effect of loss of b1 integrin expression in acinar cells during development; B6-week-old b1 integrin-deficient mice were susceptible to pancreatitis and displayed aberrant acinar cell polarity and necrosis. 15 More recently, we have begun to probe the role of b1 integrin expression in the postnatal, developed pancreas, using a tamoxifen-dependent cre recombinase expressed under the control of a collagen I-specific promoter/enhancer. We demonstrated that adult mice deficient in b1 integrin showed impaired glucose tolerance with a significant reduction in pancreatic b-cell function, consistent with the onset of diabetes. Furthermore, these b1 integrin-deficient mice displayed a significant decrease in pancreatic focal adhesion kinase and extracellular signalregulated kinase 1/2 activation, along with increased caspase-3 cleavage and decreased cyclin D1 expression. 16 However, the effects of b1 integrin deficiency on pancreatic exocrine morphology and function in conditional b1 integrindeficient mice have still to be determined.
Here, we used mice homozygous for a loxP-b1 integrin allele and hemizygous for tamoxifen-dependent cre recombinase expressed under the control of a collagen type I promoter to analyze pancreatic exocrine morphology and function in vivo. 16 We found that mice with b1 integrin deficiency controlled by the collagen I promoter had a primary defect in PSCs and islets in the pancreas, which led to a significant decrease in ECM products in the exocrine compartment. b1 integrin-deficient mice displayed significantly decreased food intake with a loss of body weight, which was associated with reduced pancreatic amylase, carboxypeptidase A and regenerating islet-derived protein II expression. These b1 integrin-deficient mice also demonstrated decreased exocrine cell proliferation and increased apoptosis. Interestingly, cultured acinar cell clusters isolated from b1 integrindeficient mouse pancreata in the presence of ECM proteins showed an improved acinar cell apoptosis. This study indicates that sufficient ECM and b1 integrin interactions are essential for maintaining exocrine pancreatic integrity and function.
MATERIALS AND METHODS Conditional b1 Integrin-Deficient Mice
To generate conditional b1 integrin-deficient mice (b1KO) in collagen I-producing cells, floxed b1 integrin mice were crossed with C57BL/6 mice containing CRE-ER T (tamoxifen-inducible cre recombinase) gene downstream of the collagen type Ia2 (Col1a2) promoter, as described previously. 17 Progeny mice with positive genotype, as analyzed by polymerase chain reaction (PCR), 17 were induced by intraperitoneal injection of 1 mg tamoxifen (4-hydroxytamoxifen; Sigma, St Louis, MO, USA) per mouse per day for 5 days at 3 weeks of age. 16 Corn oil-injected Crepositive and tamoxifen-injected Cre-negative mouse groups were merged as controls (Ctrl) and experiments were carried out on male mice at 4 and 7 weeks post-injection. Deletion of b1 integrin was confirmed by quantitative RT-PCR, western blot and immunofluorescence as described previously. 16 A Rosa26loxP-STOP-lacZ mouse (Jackson Laboratories), which does not express the b-galactosidase reporter gene unless cre recombinase is expressed in the nucleus, was crossed with
Col1a2-Cre-ER
T to identify the cells within the pancreas that expressed cre under control of the Col1a2 promoter. 17 All protocols were approved by the Animal Use Subcommittee at the University of Western Ontario in accordance with the guidelines of the Canadian Council of Animal Care.
Body and Pancreas Weight and Food Intake Studies
The body and pancreas weight of b1 integrin-deficient and control mice were measured at 4 and 7 weeks post-injection. At 4 weeks post-injection, mice from both b1 integrin-deficient and control groups were separated individually and had their food weighed daily at 0900 hours and monitored their food intake for a week. Data were expressed as average food intake per mouse per day.
Acinar Cell Culture Experiments
To isolate acinar cell clusters, both b1 integrin-deficient and control mouse pancreata at 3 weeks post-injection were dissected and digested with collagenase XI (1 mg/ml; Sigma). Acinar cell clusters were cultured in modified RPMI 1640 media 18 with either 1% BSA (Sigma) or 10% FBS (Invitrogen, Burlington, ON, Canada), reported to be enriched for ECM proteins, 19, 20 for 24 h. Cell clusters from four experimental groups (b1KO-BSA, Ctrl-BSA, b1KO-FBS, and Ctrl-FBS) were harvested and processed for immunofluorescence with at least four mouse pancreata per experimental per group used.
RNA Extraction, Real-Time RT-PCR Total RNA was extracted from pancreata of b1 integrin-deficient and control mice at 1 week post-injection using the miRNeasy kit (Qiagen, Germantown, MD, USA). 16 For each reverse transcription reaction, 2 mg of total RNA from whole pancreatic tissue were used with oligo(dT) and random primers, as well as Superscript reverse transcriptase (Invitrogen). Sequences of PCR primers used for RT-PCR with expected size of product are listed in Table 1 . Real-time RT-PCR analyses were performed as described previously. 16 Data were normalized to levels of 18S rRNA subunit and relative gene expression was calculated based on the 2 DD CT method as PCR signals from b1 integrin-deficient pancreata relative to control pancreata. 16 Protein Extraction and Western Blot Analysis b1 integrin-deficient and control pancreata, as well as acinar cell clusters, were sonicated in Nonidet-P40 lysis buffer to extract protein. Equal amounts (2 mg) of lysate pancreatic proteins from each experimental group were separated by 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophesis and transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were incubated with appropriate diluted primary antibodies as listed: mouse anti-amylase (Santa Cruz Biotechnology, Santa Cruz, CA, USA); mouse anti-carboxypeptidase A (AbD serotec; Raleigh, NC, USA); mouse anti-regenerating islet-derived protein II and goat anti-b1 integrin (R&D System, Minneapolis, MN, b1 integrin loss impairs the pancreas MM Riopel et al USA). Proteins were detected using ECLt-Plus Western blot detection reagents (Perkin-Elmer, Wellesley, MA, USA) and exposed using the Versadoc Imaging System (Bio-Rad Laboratories). Densitometric quantification of bands at subsaturation levels was performed using the Quantity One software (Bio-Rad Laboratories) and normalized to appropriate loading controls. Data are expressed as relative expression level of protein to the loading control. 16 Serum Assays for Amylase and Pancreatic Lipase Serum was collected from 7 weeks post-injected b1 integrindeficient and control mice. To measure serum amylase levels, a Phadebas Test tablet (Magle Life Sciences, Lund, Sweden) was added to diluted serum samples, based on the manufacturer's instructions. Amylase activity was measured with a spectrophotometer and determined by comparing absorbance values to a standard curve. 21 To examine the serum level of pancreatic lipase, serum samples were mixed with lipase enzyme substrate and enzyme activator as per the manufacturer's instructions. Pancreatic lipase activity was measured using a spectrophotometer and a formula offered by Genzyme Diagnostics (Charlottetown, PEI, Canada). 22 
Extracellular Matrix Protein Analysis
Pancreata from b1 integrin-deficient and control mice at 7 weeks post-injection were dissected and fixed in 4% paraformaldehyde. In all, 4-mm-thick pancreatic tissue sections were prepared from the entire length of the pancreas and stained with hematoxylin and eosin, Masson's trichrome (for total collagen analysis) and picrosirius red (for birefringent collagen I staining), as described previously. 16 To evaluate quantitatively fibronectin concentration in the pancreas of b1 integrin-deficient and control mice, a fibronectin mouse sandwich ELISA kit was used (Abcam, Cambridge, MA, USA).
Immunofluorescence and TUNEL Assay Sets of pancreatic tissue sections (4 mm thick) were immunofluorescently stained with appropriate diluted primary antibodies as listed: rabbit anti-b1 integrin (Millipore, Temecula, CA, USA); rabbit anti-Escherichia coli b-galactosidase (Abcam, Cambridge, MA, USA); mouse anti-GFAP (Pharmingen, Mississauga, ON, Canada); guinea-pig antiinsulin (Zymed, San Francisco, CA, USA) and mouse antilaminin (Developmental Studies Hybridoma Bank, Iowa City, IA, USA). Fluorescent secondary antibodies were obtained from Jackson Immunoresearch Laboratories (West Grove, PA, USA) and 4 0 -6-diamidino-2-phenylindole (Sigma) was used for nuclear counterstaining. 16 To assess the structural organization of focal adhesion contacts in pancreatic acinar cells, an Actin Cytoskeleton and Focal Adhesion Staining kit (Chemicon, Temecula, CA, USA) containing mouse anti-vinculin monoclonal antibody and TRITC-conjugated phalloidin was used. Cell proliferation was examined using Ki67 labeling (Abcam).
To examine the cells undergoing apoptosis, the terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) assay was performed. 23 Briefly, pancreatic sections were pretreated with 0.1% trypsin, and then incubated with the TUNEL reaction mixture conjugated with fluoresceindUTP (Roche, Montreal, QC, Canada). Percent cell proliferation and apoptosis were calculated by counting Ki67-or TUNEL-labeled cells in exocrine tissue from at least 12 randomly selected fields of view per pancreatic section. 16 Statistical Analysis Data are expressed as means ± s.e.m. Statistical significance was determined using the unpaired Student's t-test. Differences were considered to be statistically significant when Po0.05.
RESULTS

Loss of b1 Integrin Observed in PSCs and Islets with a Significant Reduction in ECM Expression in the Pancreas of b1 Integrin-Deficient Mice
To determine the pancreatic cell types that would be directly affected by the knockout of b1 integrin, transgenic Rosa26loxP-STOP-lacZ mice were crossed with Col1a2-CRE(ER) T mice. 17 The resultant mice were injected with tamoxifen to allow expression of b-galactosidase in cells specifically expressing cre recombinase under control of the Col1a2 promoter. Cells within the pancreas positive for b-galactosidase were detected with an anti-b-galactosidase antibody (Figure 1a) . Double labeling using an antibody directed against GFAP, a marker of PSCs, 24 revealed that the Col1a2 promoter was active in PSCs ( Figure 1a) . Moreover, b-galactosidase expression was also found in islets of the pancreas (Figure 1a) . These results (Figure 1b-g ). These results indicate that b1 integrin expression on PSCs and islets is critical in mediating ECM gene expression in the pancreas.
Disturbed Acinar Cell-Cell Contacts and Focal Contact Complex Observed in the b1 Integrin-Deficient Mouse Pancreas Loss of b1 integrin in pancreatic PSCs and islets resulted in decreased ECM expression; therefore, we set to investigate any alterations in pancreatic morphology. Based on hematoxylin and eosin stain, we found that pancreatic acini similarly organized between b1 integrin-deficient and control mice. However, the detachment of acini clusters from one another was observed along with very basophilic stain in the periphery of the acinus in b1 integrin-deficient pancreata (Figure 2a ). Masson's trichrome (Figure 2b , upper panel) and picrosirius red (Figure 2b , lower panel) staining revealed a reduction in collagen fibers and connective tissue between the acini clusters. Furthermore, analysis of pancreatic fibronectin protein levels in b1 integrin-deficient mice showed a significant decrease compared with controls (*Po0.05; Figure 2c ). Actin cytoskeleton and focal adhesion staining showed more robust cytoskeletal fibers along with more pronounced and continuous vinculin stain in control, but not b1 integrin-deficient, mouse pancreas at 7 weeks posttamoxifen injection (Figure 2d ). Likewise, there was less colocalization of F-actin and vinculin, suggesting fewer focal adhesions in 7 weeks post-tamoxifen-injected b1 integrindeficient mice when compared with controls ( Figure 2d) . Finally, anti-laminin immunofluorescence showed a dramatic loss of laminin in 7 weeks post-tamoxifen-injected b1 integrin-deficient mouse pancreas, whereas controls show clear laminin at cell-cell contacts (Figure 2e ).
Reduced b1 Integrin in Acinar Cells, along with Significantly Reduced Pancreas Weight and Food Intake Observed in b1 Integrin-Deficient Mice Although the b-galactosidase stain showed a direct effect on PSCs and islets, but not acinar cells in the b1 integrin-deficient mouse pancreas, reduced b1 integrin expression stain in the acinar cell population was observed in 1 week posttamoxifen-injected b1 integrin-deficient mice when compared with controls, but not at 3 days (Figure 3a and b) . Protein expression analyses confirm these results, indicating a significant reduction in b1 integrin in b1 integrin-deficient mice at 7 days, but not 3 days, when compared with controls (*Po0.05; Figure 3c and d) . This suggests that loss of b1 integrin expression in the acinar cells may be secondary to the loss of ECM proteins. Analysis of body and pancreas weight in 4 and 7 weeks post-tamoxifen-injected b1 integrindeficient mice showed a significantly reduced ratio of pancreas to body weight at 7 weeks post-injection when compared with control mice (*Po0.05; Figure 3e ). As well, a significant decrease in food intake was observed in 4 weeks post-tamoxifen-injected b1 integrin-deficient mice compared with controls (***Po0.001; Figure 3f ).
Significantly Reduced Amylase Expression Observed in b1 Integrin-Deficient Mice
To assess the defect of b1 integrin deficiency on exocrine pancreatic products, the expression of amylase mRNA and protein, as well as serum amylase levels, was examined. We found that b1 integrin-deficient mice compared with controls had significant decreases in amylase mRNA expression (*Po0.05; Figure 4a) , with a 50% reduction in serum amylase level (***Po0.01; Figure 4b ) and total amylase protein expression in the pancreas (*Po0.05; Figure 4d ). Furthermore, serum pancreatic lipase activity was significantly reduced in b1 integrin-deficient mice, but not controls (*Po0.05; Figure 4c ). Protein expression level of carboxypeptidase A and regenerating islet-derived protein II was also significantly decreased in b1 integrin-deficient pancreata when compared with controls at 7 weeks post-injection (*Po0.05-***Po0.01; Figure 4e and f), confirming reduced pancreatic exocrine cell function in b1 integrin-deficient mice. positive proliferating acinar cells was significantly decreased in b1 integrin-deficient mice at 7 weeks post-tamoxifen injection when compared with control mice (*Po0.05; Figure 5a ). Furthermore, a significant increase in acinar cells undergoing apoptosis was observed in b1 integrin-deficient mice (***Po0.001; Figure 5b ).
Since the primary b1 integrin defect was in PSCs and islets, we hypothesized that the pancreatic exocrine dysfunction is due to problematic ECM stimulation of acini. To investigate this, we isolated acinar cell clusters from control and b1 integrin-deficient pancreata and cultured them with or without FBS that contains rich ECM proteins. 19, 20 b1 integrindeficient acinar cell clusters cultured with BSA showed significantly increased cell apoptosis when compared with the control cell clusters (*Po0.05; Figure 5c ). However, the number of TUNEL-positive cells in b1 integrin-deficient acinar cell clusters was reduced and reached control levels when cultured with FBS medium (*Po0.05; Figure 5c ).
DISCUSSION
This study analyzed the effects of b1 integrin deficiency on pancreatic exocrine tissue. Our results demonstrate that b1 integrin deficiency under control of the collagen I promoter directly affected PSCs and islets, and this led to significantly reduced ECM protein production in the pancreas. PSCs support parenchyma by secreting ECM components that integrins use as ligands. Indeed, PSCs in human pancreatic acini stain positive for collagens I, III and IV, laminin, fibronectin and other ECM proteins. 7 Furthermore, there is a necessity of a5b1 integrin in connective tissue growth factor stimulation of PSC collagen I synthesis. 25 It has also been reported that PSC secretion of growth factors and ECM components are, in part, responsible for fibrosis in chronic pancreatitis. 8, 9 Our results support previous research, in that b1 integrin is required to maintain PSC expression of certain ECM proteins, including Col1a2, Fn1 and Lamc1.
Our observation of reduced pancreatic ECM mRNA was concomitant with disrupted cell-cell contacts between acini along with reduced connective tissue and collagen fibers, laminin immunoreactivity and acinar cell expression of b1 integrin. It is unclear precisely which process preceded the other, but studies have demonstrated that b1 integrin loss led to improper basement membrane assembly and laminin expression in teratoma 12 and embryoid bodies, 11 implicating b1 integrin as an essential part of ECM maintenance. It has also been demonstrated that ECM proteins can regulate integrin expression in human fibroblasts. 26 Ablation of b1 integrin by inactivating monoclonal antibody treatment disrupted cellcell contacts of keratinocytes. 27 Likewise, mouse mammary gland alveoli deficient of b1 integrin could not attach to the basement membrane laminin substratum. 28 This study also showed decreased focal adhesion contacts in b1 integrindeficient mammary epithelium when compared with controls. 27 Taken together, the findings of this study demonstrate that reduced b1 integrin in PSCs had a direct effect on ECM expression, which in turn effected acinar cell b1 integrin expression, cell-cell interactions, and subsequently cell proliferation and death.
b1 integrin has been well-established as upstream of the mitogen-activated protein kinase pathway, which has profound effects on cell survival and proliferation. 16, 23 Our previous analysis of b1 integrin-deficient mice demonstrated a significant reduction in focal adhesion kinase and extracellular signal-regulated kinase 1/2 phosphorylation, indicating reduced mitogen-activated protein kinase signaling. 16 Our results corroborate these studies by demonstrating a reduction in pancreatic b1 integrin, along with significantly decreased proliferation and increased apoptosis. To elucidate if the observed effects of pancreatic exocrine dysfunction were due to b1 integrin or ECM protein deficiency, isolated exocrine cell clusters from b1 integrindeficient and control mouse pancreas were cultured in ECMenriched medium. Our data indicate that apoptosis was significantly reduced in b1 integrin-deficient cell clusters when cultured in media with FBS, suggesting that supplementing ECM via FBS to b1 integrin-deficient cell clusters can improve their survival status. This strengthens our working model, whereby pancreatic exocrine defects associated with b1 integrin deficiency may be largely due to insufficient ECM proteins.
It was noted that food intake was significantly reduced in b1 integrin-deficient mice at 4 weeks post-tamoxifen injection along with a significant decrease in body weight. 16 Many studies have established a positive correlation between food consumption and weight gain. 29, 30 Food intake is controlled by a brain-gut axis associated with multiple factors including pancreatic enzyme secretion. [31] [32] [33] Our data demonstrated a significant reduction in pancreatic lipase, amylase and carboxypeptidase A expression, major enzymes produced by the exocrine pancreas, in b1 integrin-deficient mice when compared with controls, suggesting that the pancreatic insufficiency occurred because of a loss of ECM proteins and b1 integrin in the pancreas. The pancreas of b1 integrindeficient mice became significantly underweight at 7 weeks post-tamoxifen injection, 16 which was more drastic than the drop in body weight as shown by the ratio of pancreas to body weight. This ratio was significantly decreased in b1 integrin-deficient mice when compared with controls, further indicating a severe pancreatic defect. Meanwhile, other research has shown that reduction in food intake decreases serum 32 and pancreatic 33 amylase, which may be related to lower insulin levels. These studies are in line with our research, whereby b1 integrin-deficient mice display reduced pancreatic insulin along with reduced serum amylase activity and pancreatic amylase protein and mRNA expression. 16 Therefore, the lack of pancreatic ECM proteins or b1 integrin affected pancreatic enzyme levels, which may have negatively affected food intake, and thus body weight. In summary, b1 integrin-deficient mice showed significant pancreatic exocrine dysfunction compared with controls. The decrease in pancreas to body weight ratio, essential pancreatic digestive enzymes and ECM matrix expression all suggest that b1 integrin and ECM proteins have an important role in maintaining pancreatic function and differentiation. Furthermore, we observed increased cell death and reduced cell proliferation, indicating disturbed cell survival/apoptosis homeostasis. A recovery in apoptosis was observed after b1 integrin-deficient cell clusters were provided ECM proteins. Taken together, these results implicate b1 integrin as an essential component to maintain ECM expression along with exocrine pancreatic structure and function.
